Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Clinical trial NCT01392209 · COMPLETED

Trial details

NCT number: NCT01392209
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Cancer MALIGNANT GLIOMA Glioblastoma Anaplastic Astrocytoma (AA)Anaplastic Oligodendroglioma (AO)Anaplastic Oligo-astrocytoma (AOA)Anaplastic Mixed Gliomas Malignant Glioma NOS

Start date: 2011-07-08
Primary completion: 2019-11-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.